Synthetic Peptides and Peptidomimetics: From Basic Science to Biomedical Applications
This Special Issue, entitled "Synthetic Peptides and Peptidomimetics: From Basic Science to Biomedical Applications", has included both reviews and original research contributions focused on the chemical design and biomedical applications of structurally modified bioactive peptides. The pa...
Saved in:
Other Authors: | , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_87450 | ||
005 | 20220706 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20220706s2022 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-4395-6 | ||
020 | |a 9783036543963 | ||
020 | |a 9783036543956 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-4395-6 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a GP |2 bicssc | |
072 | 7 | |a PS |2 bicssc | |
100 | 1 | |a Doti, Nunzianna |4 edt | |
700 | 1 | |a Ruvo, Menotti |4 edt | |
700 | 1 | |a Doti, Nunzianna |4 oth | |
700 | 1 | |a Ruvo, Menotti |4 oth | |
245 | 1 | 0 | |a Synthetic Peptides and Peptidomimetics: From Basic Science to Biomedical Applications |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
300 | |a 1 electronic resource (274 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a This Special Issue, entitled "Synthetic Peptides and Peptidomimetics: From Basic Science to Biomedical Applications", has included both reviews and original research contributions focused on the chemical design and biomedical applications of structurally modified bioactive peptides. The papers collected show how successful this class of molecules still is, both as model molecules for studying the structure of proteins and as potential therapeutics and diagnostics, and also as laboratory tools for advanced basic and applied studies. The large scientific community working in this field is in fact very active and productive, and is making the most of the potential and versatility of these molecules to generate increasingly interesting and innovative molecules of therapeutic interest and to understand the fundamental molecular mechanisms of life. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
650 | 7 | |a Biology, life sciences |2 bicssc | |
653 | |a polymers | ||
653 | |a peptidomimetics | ||
653 | |a AFM | ||
653 | |a transfection | ||
653 | |a molecular modelling | ||
653 | |a peptide | ||
653 | |a α-helix | ||
653 | |a hydrocarbon stapling | ||
653 | |a ring-closing metathesis | ||
653 | |a i,i + 1 staple | ||
653 | |a X-ray structure | ||
653 | |a deferoxamine | ||
653 | |a RGD peptides | ||
653 | |a integrins | ||
653 | |a radiodiagnostics | ||
653 | |a PET imaging | ||
653 | |a retro-inverso peptides | ||
653 | |a anticancer peptides | ||
653 | |a drug delivery | ||
653 | |a peptide antigens | ||
653 | |a Aβ | ||
653 | |a IAPP | ||
653 | |a antimicrobial peptides | ||
653 | |a peptides | ||
653 | |a diagnostic | ||
653 | |a ELISA | ||
653 | |a microarray | ||
653 | |a PET | ||
653 | |a SPECT | ||
653 | |a imaging diagnostic | ||
653 | |a non-imaging diagnostic | ||
653 | |a amphiphilic peptides | ||
653 | |a non-viral gene delivery | ||
653 | |a nanocarrier | ||
653 | |a peptide self-assemblies | ||
653 | |a stimuli responsive | ||
653 | |a SARS-CoV-2 | ||
653 | |a FRET | ||
653 | |a molecular docking | ||
653 | |a molecular dynamics | ||
653 | |a MM-GBSA | ||
653 | |a drug repurposing | ||
653 | |a antiviral | ||
653 | |a cancer | ||
653 | |a cyclic peptide | ||
653 | |a integrin | ||
653 | |a αvβ3 | ||
653 | |a ALOS4 | ||
653 | |a melanoma | ||
653 | |a fluorescent peptide | ||
653 | |a environment-sensitive fluorophore | ||
653 | |a peptide labeling | ||
653 | |a luciferin | ||
653 | |a membrane-binding peptide | ||
653 | |a antimicrobial peptide | ||
653 | |a antitumor peptide | ||
653 | |a RGD peptide | ||
653 | |a antiproliferative activity | ||
653 | |a chirality | ||
653 | |a conformational analysis | ||
653 | |a density functional theory (DFT) | ||
653 | |a ferrocene | ||
653 | |a hydrogen bonds | ||
653 | |a peptidomimetic | ||
653 | |a X-ray | ||
653 | |a protein-protein interactions (PPIs) | ||
653 | |a voltage-gated Na+ (Nav) channels | ||
653 | |a fibroblast growth factor 14 (FGF14) | ||
653 | |a medium spiny neurons (MSNs) | ||
653 | |a nucleus accumbens (NAc) | ||
653 | |a neurotherapeutics | ||
653 | |a cyclophilin A (CypA) | ||
653 | |a apoptosis-inducing factor (AIF) | ||
653 | |a human neuroblastoma SH-SY5Y cells | ||
653 | |a staurosporine-mediated cell death | ||
653 | |a AIF(370-394) peptide | ||
653 | |a caspase-3 | ||
653 | |a PARP | ||
653 | |a antifungal | ||
653 | |a antibacterial | ||
653 | |a peptide-based therapies | ||
653 | |a synthetic peptides | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/5638 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/87450 |7 0 |z DOAB: description of the publication |